Mark Davis has served as a director since June 2024. From December 2024 to February 2026, Mr. Davis served as Senior Relationship and Growth Advisor at CrossCountry Consulting, where he has served as a member of the Advisory Council since February 2026. From 1997 to September 2024, Mr. Davis served as an audit & assurance partner at Deloitte & Touche LLP, as well as national managing partner of Deloitte Private Enterprises and managing partner of the Long Island office. Mr. Davis has served on the board of directors of Myriad Genetics, Inc. (NASDAQ: MYGN), a publicly traded molecular diagnostic testing and precision medicine company, since December 2024, where he serves as chair of the audit committee. Mr. Davis currently serves as a member of the Board of Trustees of Adelphi University. Mr. Davis is also a certified public accountant. Mr. Davis holds a B.B.A. from Adelphi University. Our Board of Directors has determined that Mr. Davis s financial skills, audit and financial services experience make him a qualified member of our Board.